Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Airway Secretion Clearance in Cystic Fibrosis

This study has been terminated.
(High dropout, problems recruiting, and smaller than expected decline in FEV1.)
Cystic Fibrosis Foundation Therapeutics
American Biosystems (currently Hill-Rom)
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: February 5, 2009
Last updated: October 1, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2003
  Primary Completion Date: December 2002 (Final data collection date for primary outcome measure)